Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 1 376.55 INR 0.7% Market Closed
Market Cap: 246.6B INR
Have any thoughts about
Natco Pharma Ltd?
Write Note

Natco Pharma Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Natco Pharma Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Natco Pharma Ltd
NSE:NATCOPHARM
Cash & Cash Equivalents
â‚ą9.5B
CAGR 3-Years
50%
CAGR 5-Years
28%
CAGR 10-Years
56%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash & Cash Equivalents
â‚ą7.1B
CAGR 3-Years
-22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash & Cash Equivalents
â‚ą9.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash & Cash Equivalents
â‚ą90.2B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash & Cash Equivalents
â‚ą11.5B
CAGR 3-Years
49%
CAGR 5-Years
14%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Cash & Cash Equivalents
â‚ą1.2B
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Natco Pharma Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
9.5B INR

Based on the financial report for Jun 30, 2024, Natco Pharma Ltd's Cash & Cash Equivalents amounts to 9.5B INR.

What is Natco Pharma Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
56%

Over the last year, the Cash & Cash Equivalents growth was 74%. The average annual Cash & Cash Equivalents growth rates for Natco Pharma Ltd have been 50% over the past three years , 28% over the past five years , and 56% over the past ten years .

Back to Top